Colon cancer stage iii and Gastrointestinal inflammation
Gastrointestinal inflammation is reported only by a few people with Colon cancer stage iii.
The study analyzes which people have Gastrointestinal inflammation with Colon cancer stage iii. It is created by eHealthMe based on 1 person who has Gastrointestinal inflammation and Colon cancer stage iii from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who has Colon Cancer Stage Iii and Gastrointestinal Inflammation is studied.
What is Colon cancer stage iii?
Colon cancer stage iii is found to be associated with 217 drugs and 106 conditions by eHealthMe.
What is Gastrointestinal inflammation?
Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 774 drugs and 512 conditions by eHealthMe.
Number of Gastrointestinal inflammation in Colon cancer stage iii reports submitted per year:
Gender of people who have Colon Cancer Stage Iii and experienced Gastrointestinal Inflammation *:
- female: 0.0 %
- male: 100 %
Age of people who have Colon Cancer Stage Iii and experienced Gastrointestinal Inflammation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common symptoms for these people *:
- Oedema (fluid collection in tissue): 1 person, 100.00%
- Metastases To Liver (cancer spreads to liver): 1 person, 100.00%
- Metastases To Large Intestine (cancer spreads to large intestine): 1 person, 100.00%
- Intestinal Ulcer: 1 person, 100.00%
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 100.00%
- Hyperplasia (enlargement of an organ or tissue): 1 person, 100.00%
- Gastrointestinal Mucosal Disorder (disorder of gastrointestinal lining mucous membranes): 1 person, 100.00%
- Gastroenteritis Bacterial (inflammation of stomach and intestine by bacterial infection): 1 person, 100.00%
- Fever: 1 person, 100.00%
- Fatigue (feeling of tiredness): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Gastrointestinal inflammation?Check whether Gastrointestinal inflammation is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .
Treatments, associated drugs and conditions:
COVID vaccines that are related to Gastrointestinal inflammation:
- Gastrointestinal inflammation in Moderna COVID Vaccine
- Gastrointestinal inflammation in Pfizer BioNTech Covid Vaccine
- Gastrointestinal inflammation in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastrointestinal inflammation:
All the drugs that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (774 drugs)
Common conditions associated with Gastrointestinal inflammation:
All the conditions that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (512 conditions)
How the study uses the data?
The study is based on Gastrointestinal inflammation and Colon cancer stage iii, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Humalog and Thrombophlebitis Superficial - now
- Naproxen and Sweating Increased - a second ago
- Bydureon Bcise and Nitrostat drug interaction - 28 seconds ago
- Droxidopa and Weight Decreased - 29 seconds ago
- Anaemia and Weight Increased - 34 seconds ago
- Zoledronic Acid and Osteopenia - 40 seconds ago
- Duloxetine Hydrochloride and Retinal Detachment - 43 seconds ago
- Penicillamine and Musculoskeletal Stiffness - 45 seconds ago
- Lotrisone and Gynecomastia - 45 seconds ago
- Colace and Indigestion - 54 seconds ago